LP-003 is named as a drug or biological intervention in 5 clinical trials in our China trial register, 1 of which is recruiting. Lead sponsors include Longbio Pharma (4) and Longbio Pharma (Suzhou) Co., Ltd. (1). Registered phases: Phase 2, Phase 3 and Phase 1. Conditions studied include Seasonal Allergic Rhinitis; Allergic Asthma; Chronic Spontaneous Urticaria.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT07342803 | Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients (ClinicalTrials.gov ↗) Allergic Asthma |
Phase 2 | Recruiting |
| NCT07313917 | A Study to Evaluate the Efficacy and Safety of LP-003 Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) (ClinicalTrials.gov ↗) Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) |
Phase 2 | Not yet open |
| NCT07816432 | A Study to Evaluate the Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Characteristics of LP-003 Injection in Participants With Wheat Allergy (ClinicalTrials.gov ↗) Food Allergy, Wheat Hypersensitivity |
Phase 2 | Not yet open |
| NCT07291284 | Efficacy and Safety of LP-003 Injection in Patients With Moderate to Severe Seasonal Allergic Rhinitis (ClinicalTrials.gov ↗) Seasonal Allergic Rhinitis |
Phase 3 | Active, closed |
| NCT06604949 | A Study of Single Dose of LP-003 in Healthy Adult Subjects (ClinicalTrials.gov ↗) Chronic Spontaneous Urticaria |
Phase 1 | Active, closed |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Seasonal Allergic Rhinitis | 1 |
| Allergic Asthma | 1 |
| Chronic Spontaneous Urticaria | 1 |
| Food Allergy | 1 |
| Wheat Hypersensitivity | 1 |
| Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | 1 |
| Lead sponsor | Trials |
|---|---|
| Longbio Pharma | 4 |
| Longbio Pharma (Suzhou) Co., Ltd. | 1 |
| Register | LP-003 trials |
|---|---|
| Clinical trials in China | 5 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how LP-003 works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists LP-003 (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.